SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
22-Mar-21 7:03 PM View: | Vistagen Therapeutics, Inc. (VTGN) | 19-Mar-21 | Option Exercise | 2,500 | $1.50 | $3,750.00 | 5% 53.25K to 55.75K | |
24-Aug-20 4:31 PM View: | Vistagen Therapeutics, Inc. (VTGN) | 21-Aug-20 | Market Purchase | 30,000 | $0.69 | $20,700.00 | 129% 23.25K to 53.25K | |
11-Jun-19 8:12 PM View: | Durect Corp. (DRRX) | 10-Jun-19 | Market Purchase | 25,000 | $0.55 | $13,749.90 | 16% 152.81K to 177.81K | (4%) |
28-May-19 7:48 PM View: | Durect Corp. (DRRX) | 24-May-19 | Market Purchase | 30,000 | $0.63 | $18,903.10 | 24% 122.81K to 152.81K | (5%) |
14-May-19 7:01 PM View: | Durect Corp. (DRRX) | 13-May-19 | Market Purchase | 40,400 | $0.70 | $28,094.80 | 90% 45.0K to 85.4K | < 1% |
15-May-19 2:43 PM View: | Durect Corp. (DRRX) | 13-May-19 | Market Purchase | 9,600 | $0.71 | $6,772.67 | 8% 113.21K to 122.81K | (5%) |
14-Mar-19 5:22 PM View: | Vistagen Therapeutics, Inc. (VTGN) | 14-Mar-19 | Market Purchase | 7,920 | $1.27 | $10,086.10 | 52% 15.33K to 23.25K | (45%) |
15-Mar-19 8:36 PM View: | Durect Corp. (DRRX) | 13-Mar-19 | Market Purchase | 21,300 | $0.82 | $17,479.90 | 107% 20.0K to 41.3K | (5%) |
15-Mar-19 8:37 PM View: | Durect Corp. (DRRX) | 13-Mar-19 | Market Purchase | 3,700 | $0.82 | $3,020.79 | 5% 69.11K to 72.81K | (4%) |
14-Mar-19 5:22 PM View: | Vistagen Therapeutics, Inc. (VTGN) | 13-Mar-19 | Market Purchase | 12,080 | $1.26 | $15,201.50 | 372% 3.25K to 15.33K | (44%) |
30-Jan-19 4:05 PM View: | Vistagen Therapeutics, Inc. (VTGN) | 29-Jan-19 | Option Exercise | 1,375 | $1.50 | $2,062.50 | 73% 1.88K to 3.25K | (53%) |
16-Oct-17 5:16 PM View: | SciClone Pharmaceuticals, I... (SCLN) | 13-Oct-17 | Disposition | 135,000 | $11.18 | $1,509,300.00 | (100%) 135.0K to 0 | < 1% |
23-Feb-17 6:27 PM View: | SciClone Pharmaceuticals, I... (SCLN) | 22-Feb-17 | Option Exercise | 12,700 | $2.61 | $33,147.00 | 10% 122.3K to 135.0K | |
17-Feb-17 11:21 AM View: | SciClone Pharmaceuticals, I... (SCLN) | 16-Feb-17 | Option Exercise | 17,300 | $2.61 | $45,153.00 | 16% 105.0K to 122.3K | |
06-Jan-16 1:40 PM View: | SciClone Pharmaceuticals, I... (SCLN) | 04-Jan-16 | Option Exercise | 30,000 | $2.46 | $73,800.00 | 40% 75.0K to 105.0K | |
05-Mar-15 2:34 PM View: | SciClone Pharmaceuticals, I... (SCLN) | 04-Mar-15 | Option Exercise | 30,000 | $3.27 | $98,100.00 | 67% 45.0K to 75.0K | |
14-Dec-12 4:40 PM View: | Durect Corp. (DRRX) | 12-Dec-12 | Market Purchase | 15,000 | $0.91 | $13,619.50 | 46% 32.81K to 47.81K | (22%) |
29-Aug-12 5:04 PM View: | Durect Corp. (DRRX) | 28-Aug-12 | Market Purchase | 5,000 | $0.98 | $4,900.00 | 18% 27.81K to 32.81K | (28%) |
29-Aug-12 5:04 PM View: | Durect Corp. (DRRX) | 27-Aug-12 | Market Purchase | 2,810 | $0.96 | $2,697.60 | 11% 25.0K to 27.81K | (26%) |
27-Aug-12 2:15 PM View: | Durect Corp. (DRRX) | 23-Aug-12 | Market Purchase | 5,000 | $1.00 | $5,000.00 | 25% 20.0K to 25.0K | (29%) |
03-May-12 1:25 PM View: | SciClone Pharmaceuticals, I... (SCLN) | 02-May-12 | Option Exercise | 20,000 | $3.84 | $76,800.00 | 80% 25.0K to 45.0K | |
16-Dec-11 8:23 PM View: | Vistagen Therapeutics, Inc. (VTGN) | 14-Dec-11 | Exercise (in-the money or at-the-money) | 2,784 | $1.25 | $3,480.00 | 16% 17.35K to 20.14K | |
24-May-11 12:35 PM View: | SciClone Pharmaceuticals, I... (SCLN) | 20-May-11 | Option Exercise | 10,000 | $5.26 | $52,600.00 | 67% 15.0K to 25.0K | |
25-May-11 6:57 PM View: | Vistagen Therapeutics, Inc. (VTGN) | 11-May-11 | Grant | 17,354 | $3.50 | $60,739.00 | 100% 0 to 17.35K | |
28-May-08 4:06 PM View: | Sciele Pharma Inc. (SCRX) | 23-May-08 | Option Exercise | 3,750 | -- | -- | 20% 18.5K to 22.25K | |
28-May-08 4:06 PM View: | Sciele Pharma Inc. (SCRX) | 23-May-08 | Market Option Sale | 3,750 | $21.08 | $79,050.00 | (17%) 22.25K to 18.5K | (4%) |
10-Apr-08 10:41 AM View: | PDL BioPharma Inc. (PDLI) | 09-Apr-08 | Option Exercise | 120,000 | $4.25 | $510,000.00 | 40% 301.68K to 421.68K | 210% |
01-Apr-08 11:17 AM View: | PDL BioPharma Inc. (PDLI) | 28-Mar-08 | Option Exercise | 93,200 | $9.66 | $899,958.00 | 45% 208.48K to 301.68K | 10% |
10-Mar-08 6:20 PM View: | PDL BioPharma Inc. (PDLI) | 06-Mar-08 | Option Exercise | 20,600 | $9.66 | $198,918.00 | 11% 187.88K to 208.48K | 11% |
05-Mar-08 6:56 PM View: | PDL BioPharma Inc. (PDLI) | 03-Mar-08 | Option Exercise | 35,360 | $9.66 | $341,443.00 | 23% 152.52K to 187.88K | 11% |
28-Feb-08 6:55 PM View: | PDL BioPharma Inc. (PDLI) | 27-Feb-08 | Option Exercise | 10,840 | $9.66 | $104,673.00 | 8% 141.68K to 152.52K | |
23-Nov-07 6:04 PM View: | SciClone Pharmaceuticals, I... (SCLN) | 21-Nov-07 | Market Purchase | 5,000 | $1.89 | $9,456.08 | 50% 10.0K to 15.0K | 375% |
23-Nov-07 6:04 PM View: | SciClone Pharmaceuticals, I... (SCLN) | 20-Nov-07 | Market Purchase | 10,000 | $1.90 | $18,979.70 | 100% 0 to 10.0K | 374% |
13-Sep-07 2:11 PM View: | Insite Vision Inc. (INSV) | 13-Sep-07 | Market Purchase | 15,000 | $1.09 | $16,350.00 | 68% 22.0K to 37.0K | (45%) |
27-Apr-07 2:52 PM View: | Sciele Pharma Inc. (SCRX) | 25-Apr-07 | Grant | 10,000 | $25.33 | $253,300.00 | 54% 18.5K to 28.5K | (15%) |
08-Nov-06 2:43 PM View: | PDL BioPharma Inc. (PDLI) | 06-Nov-06 | Option Exercise | 40,000 | $6.62 | $265,000.00 | 39% 101.68K to 141.68K | |
02-Nov-06 4:17 PM View: | Sciele Pharma Inc. (SCRX) | 31-Oct-06 | Option Exercise | 15,000 | -- | -- | 136% 11.0K to 26.0K | |
02-Nov-06 4:17 PM View: | Sciele Pharma Inc. (SCRX) | 31-Oct-06 | Market Option Sale | 7,500 | $21.83 | $163,727.00 | (29%) 26.0K to 18.5K | 2% |
21-Jul-06 10:00 PM View: | PDL BioPharma Inc. (PDLI) | 19-Jul-06 | Option Exercise | 30,000 | $6.62 | $198,750.00 | 42% 71.68K to 101.68K | |
19-Jun-06 10:00 PM View: | Sciele Pharma Inc. (SCRX) | 15-Jun-06 | Grant | 2,500 | $22.19 | $55,487.50 | 29% 8.5K to 11.0K | (4%) |
01-Jun-06 10:00 PM View: | PDL BioPharma Inc. (PDLI) | 30-May-06 | Option Exercise | 30,000 | $6.62 | $198,750.00 | 72% 41.68K to 71.68K | |
05-May-06 6:01 PM View: | PDL BioPharma Inc. (PDLI) | 04-May-06 | Option Exercise | 40,000 | $6.62 | $265,000.00 | 2381% 1.68K to 41.68K | |
20-Apr-06 5:51 PM View: | PDL BioPharma Inc. (PDLI) | 18-Apr-06 | Market Sale (Planned) | 5,000 | $30.01 | $150,046.00 | (75%) 6.68K to 1.68K | 61% |
12-Apr-06 5:00 PM View: | PDL BioPharma Inc. (PDLI) | 10-Apr-06 | Market Sale (Planned) | 5,000 | $30.58 | $152,912.00 | (43%) 11.68K to 6.68K | 62% |
05-Apr-06 4:31 PM View: | PDL BioPharma Inc. (PDLI) | 03-Apr-06 | Market Sale (Planned) | 10,000 | $32.78 | $327,798.00 | (46%) 21.68K to 11.68K | 65% |
31-Mar-06 5:56 PM View: | PDL BioPharma Inc. (PDLI) | 29-Mar-06 | Market Sale (Planned) | 5,000 | $32.00 | $160,004.00 | (19%) 26.68K to 21.68K | 64% |
29-Mar-06 5:00 PM View: | PDL BioPharma Inc. (PDLI) | 27-Mar-06 | Market Sale (Planned) | 5,000 | $31.25 | $156,244.00 | (16%) 31.68K to 26.68K | 63% |
22-Mar-06 4:51 PM View: | PDL BioPharma Inc. (PDLI) | 20-Mar-06 | Market Sale (Planned) | 10,000 | $32.24 | $322,363.00 | (24%) 41.68K to 31.68K | 64% |
15-Mar-06 3:22 PM View: | PDL BioPharma Inc. (PDLI) | 13-Mar-06 | Market Sale (Planned) | 10,000 | $31.72 | $317,229.00 | (19%) 51.68K to 41.68K | 63% |
10-Mar-06 6:14 PM View: | PDL BioPharma Inc. (PDLI) | 08-Mar-06 | Market Sale (Planned) | 5,000 | $32.12 | $160,620.00 | (9%) 56.68K to 51.68K | 64% |